13F-HR filed by Blue Water Life Science Advisors, LP
Blue Water Life Science Advisors, LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 9 holding rows worth $114,165,458.
- Accession
- 0001172661-24-001487
- Filer
- CIK 1789778
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 9 entries on the cover page, a total value of $114,165,458 stated on the cover page (in dollars after the unit check, H1), rows summing to $114,165,458 with VALUE read as dollars as filed, 13F file number 028-20810. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NATERA INC COM | 632307104 | Stock | 397,436 | $24,895,391 | dollars as filed | |
| AKOYA BIOSCIENCES INC COM | 00974H104 | Stock | 4,697,785 | $22,925,191 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 571,047 | $15,446,821 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 25,800 | $13,694,382 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 194,500 | $10,884,220 | dollars as filed | |
| MAXCYTE INC | 57777K106 | COM | 1,885,000 | $8,859,500 | dollars as filed | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 1,687,665 | $8,269,559 | dollars as filed | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 288,196 | $7,879,279 | dollars as filed | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 1,751,891 | $1,311,115 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-24-001487 | this filing | 2024-02-14 | acceptance time not in the bulk data set |